Sino Biological Inc.

Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological’s products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological is the researchers’ one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.

Application note: Afucosylated mAb expression & antibody efficacy

Whitepaper: Recombinant protein expression using a BEVS

Whitepaper: In-depth look into anti-idiotype antibodies

Article: Bispecific antibodies: Rising stars in antibody therapeutics

Whitepaper: SARS-CoV-2 Omicron spike protein and antibodies available

Catalogue: Resources for COVID-19 and influenza vaccine development

Catalogue: Cytokines and growth factors from Sino Biological

Catalogue: Drug target reagents

Resource library: Reagent resource for studying SARS-CoV-2 variants

Sino Biological announces construction of its new US-Based centre for bioprocessing

Sino Biological and Ainnocence partner to offer next-generation antibody development CRO services

Sino Biological invests over 200M RMB to establish new subsidiaries in Taizhou and Suzhou, China

Sino Biological establishes new location in Houston, Texas

Sino Biological deposits recombinant Omicron proteins and antibodies to BEI Resources

Sino Biological launches panel of research reagents for SARS-CoV-2 Omicron variant (B.1.1.529)

Video: Sino Biological: the global leader in recombinant technology